Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 08:54 am Purchase | 2023-12-29 | 13G | Altair Engineering Inc. ALTR | PICTET ASSET MANAGEMENT SA | 970 5.300% | 970 (New Position) | Filing History |
| 2024-01-30 10:56 am Sale | 2023-12-29 | 13G | BELLUS Health Inc. BLU | PICTET ASSET MANAGEMENT SA | 0 0.000% | -6,537,360 (Position Closed) | Filing History |
| 2023-02-03 12:03 pm Sale | 2022-12-31 | 13G | IROBOT CORPORATION IRBTQ | PICTET ASSET MANAGEMENT SA | 40,375 0.150% | -1,237,792 (-96.84%) | Filing History |
| 2023-02-03 11:58 am Sale | 2022-12-31 | 13G | Molecular Templates, Inc. MTEM | PICTET ASSET MANAGEMENT SA | 120,184 3.200% | -99,884 (-45.39%) | Filing History |
| 2023-02-03 11:56 am Sale | 2022-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX | PICTET ASSET MANAGEMENT SA | 0 0.000% | -128,714 (Position Closed) | Filing History |
| 2023-02-03 11:51 am Sale | 2022-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | PICTET ASSET MANAGEMENT SA | 1,234,193 3.570% | -2,314,456 (-65.22%) | Filing History |
| 2023-02-03 11:50 am Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | PICTET ASSET MANAGEMENT SA | 1,232,713 2.590% | 1,174,029 (+2000.59%) | Filing History |
| 2023-02-03 11:46 am Sale | 2022-12-31 | 13G | Tetra Tech, Inc. TTEK | PICTET ASSET MANAGEMENT SA | 13,611,985 5.110% | -321,160 (-2.31%) | Filing History |
| 2023-02-03 11:43 am Sale | 2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | PICTET ASSET MANAGEMENT SA | 0 0.000% | -100,773 (Position Closed) | Filing History |
| 2023-02-03 11:42 am Sale | 2021-12-31 | 13G | Western Forest Products Inc. WFSTF | PICTET ASSET MANAGEMENT SA | 521,659 4.940% | -138,960 (-21.03%) | Filing History |
| 2023-02-03 11:40 am Sale | 2022-12-31 | 13G | West Fraser Timber Co. Ltd. WFG | PICTET ASSET MANAGEMENT SA | 3,750,988 4.610% | -2,112,583 (-36.03%) | Filing History |
| 2023-02-03 11:28 am Purchase | 2022-12-31 | 13G | BELLUS Health Inc. BLU | PICTET ASSET MANAGEMENT SA | 6,537,360 5.170% | 6,537,360 (New Position) | Filing History |
| 2022-02-10 11:16 am Purchase | 2022-02-09 | 13G | Annexon, Inc. ANNX | PICTET ASSET MANAGEMENT SA | 58,684 5.630% | 58,684 (New Position) | Filing History |
| 2022-02-10 11:14 am Purchase | 2022-02-09 | 13G | Spyre Therapeutics, Inc. SYRE | PICTET ASSET MANAGEMENT SA | 98,725 5.000% | 98,725 (New Position) | Filing History |
| 2022-02-10 11:13 am Purchase | 2021-12-31 | 13G | West Fraser Timber Co. Ltd. WFG | PICTET ASSET MANAGEMENT SA | 5,863,571 5.530% | 5,863,571 (New Position) | Filing History |
| 2022-02-10 11:11 am Purchase | 2022-02-09 | 13G | IROBOT CORPORATION IRBTQ | PICTET ASSET MANAGEMENT SA | 1,581,077 5.860% | 1,581,077 (New Position) | Filing History |
| 2022-02-10 11:10 am Purchase | 2022-02-10 | 13G | Neoleukin Therapeutics, Inc. NLTX | PICTET ASSET MANAGEMENT SA | 128,714 6.070% | 128,714 (New Position) | Filing History |
| 2022-02-10 11:09 am Sale | 2022-02-10 | 13G | Tetra Tech, Inc. TTEK | PICTET ASSET MANAGEMENT SA | 13,933,145 5.170% | -349,275 (-2.45%) | Filing History |
| 2022-02-10 11:07 am Purchase | 2021-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | PICTET ASSET MANAGEMENT SA | 3,548,649 5.150% | 3,548,649 (New Position) | Filing History |
| 2022-02-10 11:06 am Purchase | 2021-12-31 | 13G | Molecular Templates, Inc. MTEM | PICTET ASSET MANAGEMENT SA | 220,068 5.860% | 220,068 (New Position) | Filing History |